ARTICLE
1 February 2024

Holland & Knight Health Dose: January 24, 2024

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Congress Passes Continuing Resolution Into Early March
  • Members of Congress Urge HHS to Permanently Extend Telehealth Flexibilities
  • Bicameral Legislation to Expand Hospital-Based Addiction Medicine Residency Training Slots
  • Top Republican on Senate HELP Committee Continues Investigation Into 340B Revenues
  • House Budget Committee Approves New Bipartisan Fiscal Commission
  • Senate Committees Convene to Discuss Long COVID, Assisted Living Facilities, Patent Reform
  • Next Week: Senate HELP Committee to Vote on Subpoenas
  • Retirements
  • Centers for Medicare and Medicaid Services Releases Prior Authorization 2024 Final Rule
  • CMS Announces New Innovation in Behavioral Health Model
  • Independent Dispute Resolution Operations Rule Comment Period Will Reopen for 14 Days
  • Advanced Research Projects Agency for Health Launches PARADIGM Program
  • FDA Extends NARCAN Shelf Life
  • FDA Approves CRISPR Therapy Casgevy for Second Indication
  • HHS, Departments of Labor and Treasury Issue New Contraception Guidance
  • GAO Reports on Workforce and Veteran Maternal Health
  • Chevron Cases Pose Potential Implications for HHS Agencies
  • Biden Administration Concedes to D.C. District Court on Copay Accumulator Suit
  • World Health Organization Releases Health Artificial Intelligence Guidance

Read the full Health Dose »

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
1 February 2024

Holland & Knight Health Dose: January 24, 2024

United States Food, Drugs, Healthcare, Life Sciences

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More